AVS 61st International Symposium & Exhibition
    Surface Modification of Materials by Plasmas for Medical Purposes Focus Topic Thursday Sessions
       Session SM+AS+BI+PS-ThA

Paper SM+AS+BI+PS-ThA8
Three-Dimensional Biopolymeric Scaffold Surface Modification Using Plasma Enhanced Chemical Vapor Deposition: The Effect of Functionality and Wettability on Cell and Bacterial Attachment

Thursday, November 13, 2014, 4:40 pm, Room 315

Session: Plasma Processing of Biomemetic Materials
Presenter: Morgan Hawker, Colorado State University
Authors: M.J. Hawker, Colorado State University
A. Pegalajar-Jurado, Colorado State University
E.R. Fisher, Colorado State University
Correspondent: Click to Email

Three-dimensional (3D) bioresorbable polymeric materials, such as porous scaffolds made of poly(ε-caprolactone) (PCL), have desirable bulk properties for tissue engineering, wound healing, and controlled-release drug delivery applications. However, the surface properties (e.g., chemical functionality and wettability) are often undesirable for certain biomedical applications. Therefore, the ability to fabricate 3D materials with ideal bulk properties and customizable surface properties is a critical aspect of biomaterial development. Here, we demonstrate the deposition of conformal films throughout the 3D porous scaffold network using plasma enhanced chemical vapor deposition (PECVD). Resulting film properties can be tailored by using different precursor species. Octofluoropropane (C3F8) and hexafluoropropylene oxide (HFPO) precursors were chosen as model hydrophobic film PECVD systems, whereas a copolymerization system consisting of allylamine/allyl alcohol (allylNH/allylOH) precursors was chosen as a model hydrophilic, nitrogen containing PECVD system. To ensure the efficiency and reproducibility of the treatments, both the exterior and interior of the plasma treated scaffolds were characterized using contact angle goniometry, X-ray photoelectron spectroscopy (XPS), and scanning electron microscopy (SEM) to assess changes in wettability, chemical functionality, and scaffold architecture in comparison to untreated scaffolds. C3F8 and HFPO PECVD on scaffolds resulted in fluorocarbon films on the exterior of the scaffold, and the extent of deposition throughout the scaffold’s 3D structure was controlled by treatment time. The nitrogen content of the allylNH/allylOH films was tailored by changing the feed gas composition of the copolymerized films. After surface modifications, modified PCL scaffold surface interactions with cells and bacteria were assessed to confirm the relevance of these coatings for the biomedical field. We also explored the effect of different plasma treatments on cell adhesion/proliferation using both human dermal fibroblasts and endothelial cells, bacterial attachment, and biofilm formation using Escherichia coli.